The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones

Journal of Controlled Release

Volumn 66, Issue 2-3, 2000, Pages 127-133

  Chang, Shu Lun ^a   Hofmann, Günter A ^b   Zhang, Lei ^b   Deftos, Leonard J ^c   Banga, Ajay K ^d  

^a AUBURN UNIVERSITY   (United States)

^b Inovio Biomedical Corporation   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MERCER UNIVERSITY   (United States)

Author keywords

Calcitonin; Electroporation; Iontophoresis; Parathyroid hormone; Skin transport

Indexed keywords

APROTININ; BENZALKONIUM CHLORIDE; BUFFER; CITRIC ACID; IODINE 125; PARATHYROID HORMONE[1-34]; SALCATONIN;

ARTICLE; CADAVER; CALCIUM METABOLISM; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPORATION; EPIDERMIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IONTOPHORESIS; PH; PRIORITY JOURNAL; PULSE GENERATOR; SKIN PENETRATION; TECHNIQUE; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; CALCITONIN; DRUG DELIVERY SYSTEMS; ELECTROPORATION; EPIDERMIS; FEMALE; HUMANS; IONTOPHORESIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; PEPTIDE FRAGMENTS;

EID: 0034657103     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00262-X     Document Type: Article

References (16)

1. Banga A.K., Chien Y.W. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Control. Release. 7:1988;1-24.
2. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin - a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. 90:1993;10504-10508.
3. Edwards D.A., Prausnitz M.R., Langer R., Weaver J.C. Analysis of enhanced transdermal transport by skin electroporation. J. Control. Release. 34:1995;211-221.
4. Prausnitz M.R. Do high-voltage pulses cause changes in skin structure? J. Control. Release. 40:1996;321-326.
5. Bommannan D.B., Tamada J., Leung L., Potts R.O. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11:1994;1809-1814.
6. Vanbever R., LeBoulenge E., Preat V. Transdermal delivery of fentanyl by electroporation. 1. Influence of electrical factors. Pharm. Res. 13:1996;559-565.
7. Vanbever R., Lecouturier N., Preat V. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 11:1994;1657-1662.
8. Deftos L.J. Clinical Essentials of Calcium and Skeletal Disorders. 1998;Professional Communications.
9. Morimoto K., Iwakura Y., Nakatani E., Miyazaki M., Tojima H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J. Pharm. Pharmacol. 44:1992;216-218.
10. Thysman S., Hanchard C., Preat V. Human calcitonin delivery in rats by iontophoresis. J. Pharm. Pharmacol. 46:1994;725-730.
11. Santi P., Colombo P., Bettini R., Catellani P.L., Minutello A., Volpato N.M. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm. Res. 14:1997;63-66.
12. Boericke K., O'Connell M.A., Bock C.R., Green P., Down J.A. Iontophoretic delivery of human parathyroid hormone (1-34) in swine. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 23:1996;200-201.
13. Singh P., Frullani K., Dinh S., Liu P. In vitro and in vivo transdermal iontophoresis of PTH. Pharm. Sci. Suppl. 1:1998;S104.
14. Nabuchi Y., Fujiwara E., Kuboniwa H., Asoh Y., Ushio H. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues. Pharm. Res. 14:1997;1685-1690.
15. Szollar S.M., Martin E.M.E., Sartoris D.J., Parthemore J.G., Deftos L.J. Bone mineral density and indices of bone mineral metabolism in spinal cord injury. Am. J. Phys. Med. Rehab. 77:1998;28-35.
16. Catherwood B.D., Deftos L.J. Bikle D.D. Assays of Calcium Regulating Hormones. 1984;151 Springer-Verlag, New York.